Literature DB >> 4197358

Intestinal absorption of disodium ethane-1-hydroxy-1,1-diphosphonate (disodium etidronate) using a deconvolution technique.

R R Recker, P D Saville.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4197358     DOI： 10.1016/0041-008x(73)90219-6

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN： 0041-008X            Impact factor:   4.219


× No keyword cloud information.
  19 in total

1.  The inhibition of calcium oxalate crystal growth by multidentate organic phosphonates.

Authors:  J L Meyer; K E Lee; J H Bergert
Journal:  Calcif Tissue Res       Date:  1977-05-31

2.  Disrupting antibiotic resistance propagation by inhibiting the conjugative DNA relaxase.

Authors:  Scott A Lujan; Laura M Guogas; Heather Ragonese; Steven W Matson; Matthew R Redinbo
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-13       Impact factor: 11.205

3.  The clearance and bioavailability of pamidronate in patients with breast cancer and bone metastases.

Authors:  P T Daley-Yates; D J Dodwell; M Pongchaidecha; R E Coleman; A Howell
Journal:  Calcif Tissue Int       Date:  1991-12       Impact factor: 4.333

Review 4.  Bisphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease.

Authors:  H Fleisch
Journal:  Drugs       Date:  1991-12       Impact factor: 9.546

5.  [Diphosphonate for the prevention of an increased ossification process].

Authors:  W Forth
Journal:  Klin Wochenschr       Date:  1986-06-16

6.  A double-blind, multicentre, placebo-controlled study of tiludronate in Paget's disease of bone.

Authors:  W D Fraser; T C Stamp; R A Creek; J P Sawyer; C Picot
Journal:  Postgrad Med J       Date:  1997-08       Impact factor: 2.401

7.  Risedronate pharmacokinetics and intra- and inter-subject variability upon single-dose intravenous and oral administration.

Authors:  D Y Mitchell; W H Barr; R A Eusebio; K A Stevens; F P Duke; D A Russell; J D Nesbitt; J H Powell; G A Thompson
Journal:  Pharm Res       Date:  2001-02       Impact factor: 4.200

Review 8.  Bisphosphonates in bone diseases.

Authors:  R W Sparidans; I M Twiss; S Talbot
Journal:  Pharm World Sci       Date:  1998-10

Review 9.  Bisphosphonates and the treatment of bone disease in the elderly.

Authors:  A Johansen; M Stone; F Rawlinson
Journal:  Drugs Aging       Date:  1996-02       Impact factor: 3.923

10.  Low dose intravenous 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (APD) for the treatment of Paget's disease of bone.

Authors:  J A Cantrill; H M Buckler; D C Anderson
Journal:  Ann Rheum Dis       Date:  1986-12       Impact factor: 19.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.